GeneFerm Biotechnology Co., Ltd. (TPEX:1796)
Taiwan · Delayed Price · Currency is TWD 35.90
0.00 (0.00%)
May 29, 2026, 1:30 PM CST
GeneFerm Biotechnology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 15.7 | 28.86 | -22.53 | 124.62 | 93.45 | 57.41 |
Depreciation & Amortization | 73.53 | 74.48 | 79.36 | 73.49 | 50.03 | 45.36 |
Loss (Gain) From Sale of Assets | -0.05 | 0.28 | -0.02 | -0.01 | 0.11 | -0.04 |
Provision & Write-off of Bad Debts | -0.02 | -0.04 | -1.09 | -0.43 | -0.72 | 1.44 |
Other Operating Activities | -1.55 | 0.05 | -34.31 | 5.11 | 1.06 | 24.97 |
Change in Accounts Receivable | 12.29 | -3.94 | 11.92 | -6.86 | 4.51 | -33.4 |
Change in Inventory | -25.08 | -18.82 | -15.47 | -9.38 | -30.94 | -8.14 |
Change in Accounts Payable | 2.06 | 3.64 | 3.94 | -3.23 | 0.19 | -0.43 |
Change in Unearned Revenue | 9.96 | 11.46 | 6.71 | -1.85 | -0.67 | 1.33 |
Change in Other Net Operating Assets | -0.53 | 3.35 | -20.42 | 8.85 | 5.4 | 23.72 |
Operating Cash Flow | 86.31 | 99.31 | 8.09 | 190.31 | 122.43 | 112.23 |
Operating Cash Flow Growth | 323.41% | 1127.59% | -95.75% | 55.44% | 9.09% | 98.93% |
Capital Expenditures | -25.22 | -23.42 | -22.4 | -69.94 | -278.18 | -144.88 |
Sale of Property, Plant & Equipment | 0.05 | 0.21 | 0.03 | 0.01 | 0.04 | 0.04 |
Sale (Purchase) of Intangibles | - | - | -0.3 | -1.46 | -0.24 | -0.72 |
Other Investing Activities | 0.18 | 0.63 | -0.16 | 0.78 | -1.95 | 0.31 |
Investing Cash Flow | -24.98 | -22.59 | -22.83 | -70.62 | -280.33 | -145.26 |
Short-Term Debt Issued | - | 50 | 80 | 240 | 45 | - |
Long-Term Debt Issued | - | 120 | 171 | - | - | 5 |
Total Debt Issued | 50 | 170 | 251 | 240 | 45 | 5 |
Short-Term Debt Repaid | - | -50 | -120 | -245 | - | - |
Long-Term Debt Repaid | - | -38.94 | -31.7 | -32.68 | -285.33 | -74.17 |
Total Debt Repaid | -89.75 | -88.94 | -151.7 | -277.68 | -285.33 | -74.17 |
Net Debt Issued (Repaid) | -39.75 | 81.06 | 99.3 | -37.68 | -240.33 | -69.17 |
Issuance of Common Stock | - | - | - | - | - | 297.36 |
Common Dividends Paid | - | - | -82.92 | -62.19 | -41.46 | -3.39 |
Financing Cash Flow | -39.75 | 81.06 | 16.38 | -99.87 | -281.79 | 224.81 |
Foreign Exchange Rate Adjustments | 0.12 | 0.02 | 0.65 | -0.36 | 0.76 | -0.19 |
Net Cash Flow | 21.7 | 157.81 | 2.3 | 19.46 | -438.92 | 191.59 |
Free Cash Flow | 61.09 | 75.89 | -14.31 | 120.37 | -155.74 | -32.65 |
Free Cash Flow Margin | 9.20% | 11.21% | -2.74% | 15.17% | -24.57% | -6.25% |
Free Cash Flow Per Share | 1.47 | 1.83 | -0.34 | 2.89 | -3.66 | -0.70 |
Cash Interest Paid | 6.15 | 6.15 | 4.42 | 4.15 | 2.74 | 1.23 |
Cash Income Tax Paid | 0.16 | 0.16 | 34.43 | 20.28 | 20.86 | -1.97 |
Levered Free Cash Flow | 122.73 | 65.09 | -14.32 | 67.65 | -169.4 | -49.01 |
Unlevered Free Cash Flow | 126.65 | 68.98 | -11.55 | 70.26 | -167.01 | -44.44 |
Change in Working Capital | -1.3 | -4.32 | -13.32 | -12.47 | -21.5 | -16.91 |